Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mothaffar F Rimawi, MD
Baylor College of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
179 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uz Leuven
Leuven, Belgium
Recruiting
- Sainte-Catherine - Institut Du Cancer Avignon-Provence (icap)
Avignon, France
Recruiting - Clinique Pasteur-Lanroze
Brest, France
Recruiting - Centre François Baclesse (clcc)
Caen, France
Recruiting - Pôle Santé Léonard de Vinci
Chambray-lès-Tours, France
Recruiting - Centre Hospitalier de Cholet
Cholet, France
Recruiting - Centre Hospitalier Alpes Leman
Contamine-sur-Arve, France
Recruiting - Centre Léon Bérard
Lyon, France
Recruiting - Hôpital Privé Du Confluent
Nantes, France
Recruiting - Centre Hospitalier Privé Sainte-Marie Osny
Osny, France
Recruiting - Institut Curie
Paris, France
Recruiting - Hospices Civils de Lyon
Pierre-Bénite, France
Not, yet, recruiting - Hôpital Novo (nord-Ouest Val-D'Oise)
Pontoise, France
Recruiting - Institut Jean Godinot (clcc)
Reims, France
Recruiting - Institut Curie
Saint-Cloud, France
Recruiting - Centre Hospitalier Privé Saint-Grégoire
Saint-Grégoire, France
Recruiting - Centre Hospitalier Universitaire de Saint-Étienne
Saint-Priest-en-Jarez, France
Recruiting - Centre Lutte Contre Le Cancer Paul Strauss
Strasbourg, France
Recruiting - Hôpital Privé Drôme Ardèche
Valence, France
Recruiting - Hopitaux Prives de Metz
Vantoux, France
Recruiting - Institut Gustave Roussy
Villejuif, France
Recruiting
- Haematologie-Onkologie Im Zentrum Mvz Gmbh
Augsburg, Germany
Recruiting - Klinikum Bayreuth Gmbh
Bayreuth, Germany
Not, yet, recruiting - Helios Klinikum Berlin-Buch Gmbh
Berlin, Germany
Recruiting - Marienhospital Bottrop Ggmbh
Bottrop, Germany
Recruiting - Studien Gbr Braunschweig
Braunschweig, Germany
Not, yet, recruiting - Evangelisches Diakonie-Krankenhaus Ggmbh
Bremen, Germany
Recruiting - Klinikum Chemnitz Ggmbh
Chemnitz, Germany
Not, yet, recruiting - Städtisches Klinikum Dessau
Dessau, Germany
Recruiting - Klinikum Dortmund Ggmbh
Dortmund, Germany
Not, yet, recruiting - Universitaetsklinikum Carl Gustav Carus Dresden An Der Technischen Universitaet Dresden Aör
Dresden, Germany
Not, yet, recruiting - Kostara Gyn Oncology Clinic Research Ug
Düsseldorf, Germany
Recruiting - Studienzentrale Für Das Mvz Eggenfelden E.K.
Eggenfelden, Germany
Recruiting - Evangelisches Kliniken Essen-Mitte Ggmbh
Essen, Germany
Recruiting - Klinikum Frankfurt Höchst Gmbh
Frankfurt, Germany
Recruiting - Praxis Für Interdisziplinäre Onkologie Und Haematologie Gbr
Freiburg im Breisgau, Germany
Recruiting - Helios Klinikum Gifhorn Gmbh
Gifhorn, Germany
Recruiting - Universitätsmedizin Göttingen
Göttingen, Germany
Recruiting - Krankenhaus St. Elisabeth Und St. Barbara Halle (saale) Gmbh
Halle, Germany
Recruiting - Mammazentrum Hamburg Mvz Gbr
Hamburg, Germany
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Aug 2022
- Primary completion
- 31 Dec 2026
- Completion
- 31 Dec 2026
- Last update posted
- 4 Jun 2026
- Registered enrollment
- 750
- Registry id
- NCT05232916
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.